Document Detail


Regulation of xenogeneic porcine pancreatic islets.
MedLine Citation:
PMID:  20955290     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The use of xenogeneic porcine pancreatic islets has been shown to be a potentially promising alternative to using human allogeneic islets to treat insulin-dependent type 1 diabetes (T1D). This article provides an overview of the existing FDA regulatory framework that would be applied to the regulation of clinical trials utilizing xenogeneic porcine pancreatic islets to treat T1D.
Authors:
Judith A Arcidiacono; Evgenij Evdokimov; Mark H Lee; Jeff Jones; Larisa Rudenko; Bruce Schneider; Phillip J Snoy; Cheng-Hong Wei; Allen K Wensky; Keith Wonnacott
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Xenotransplantation     Volume:  17     ISSN:  1399-3089     ISO Abbreviation:  Xenotransplantation     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-10-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9438793     Medline TA:  Xenotransplantation     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  329-37     Citation Subset:  IM    
Copyright Information:
© 2010 John Wiley & Sons A/S.
Affiliation:
FDA, Center for Biologics Evaluation and Research (CBER), Office of Cellular, Tissue and Gene Therapies, Rockville, MD 20852, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Status epilepticus induced by putrid salted gray Mullet fish intoxication in patients with chronic K...
Next Document:  The immunology of corneal xenotransplantation: a review of the literature.